Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | NSD2 | O96028 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.46 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.46 |
| ▸ | ERN1 | O75460 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29362162 | 0.89 | PTPN22 (0.65) | PTPN22POLBHSD17B10CYP1A2USP2 | |
| SCHEMBL15400598 | 0.89 | PTPN22 (0.65) | PTPN22POLBHSD17B10CYP1A2USP2 | |
| SCHEMBL29027 | 0.89 | PTPN22 (0.65) | PTPN22POLBHSD17B10CYP1A2USP2 | |
| Hydrogen Sulfide SCHEMBL30378374 | 0.87 | PTPN22 (0.62) | PTPN22POLBHSD17B10CYP1A2USP2 | |
| SCHEMBL16291794 | 0.87 | PTPN22 (0.62) | PTPN22POLBHSD17B10CYP1A2USP2 | |
| Methane SCHEMBL10406101 | 0.87 | PTPN22 (0.62) | PTPN22POLBHSD17B10CYP1A2USP2 | |
| SCHEMBL9875431 | 0.87 | PTPN22 (0.62) | PTPN22POLBHSD17B10CYP1A2USP2 | |
| Water SCHEMBL18660620 | 0.87 | PTPN22 (0.62) | PTPN22POLBHSD17B10CYP1A2USP2 | |
| Charcoal, Activated SCHEMBL30539223 | 0.87 | PTPN22 (0.62) | PTPN22POLBHSD17B10CYP1A2USP2 | |
| SCHEMBL5417907 | 0.87 | ALDH1A1 (0.58) | PTPN22HSD17B10CYP1A2MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7351835-B2 | Organic molecular cataylst having binaphthol skeleton and processes for producing the same and application thereof | MEIJI SEIKA KAISHA LTD. (JP) | 2008-04-01 | — | — | US | disclosed |
| US-20060009646-A1 | Novel organic molecular catalyst having binaphthol skeketon and processes for producing the same and application thereof | MEIJI SEIKA KAISHA LTD. (JP) | 2006-01-12 | — | — | US | disclosed |
| EP-0614901-B1 | Phosphine compound and transition metal-phosphine complex containing the same as ligand | MITSUBISHI GAS CHEMICAL CO (JP) | 1998-08-12 | — | — | EP | disclosed |
| US-5530150-A | HAVING PHOSPHINE AND PHOSPHITE GROUPS IN SAME MOLECULE; CATALYST SELECTIVITY | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1996-06-25 | — | — | US | disclosed |
| EP-0614901-A1 | Phosphine compound and transition metal-phosphine complex containing the same as ligand | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1994-09-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060009646-A1 | Novel organic molecular catalyst having binaphthol skeketon and processes for producing the same and application thereof | SQLE, OGDH, CYP17A1 | PTPN22 4555/4885POLB 121/4885HSD17B10 1069/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.